US1167941087
© BusinessWire
10.12.2025
BRKR
LISTED
NASDAQ
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance systems from three leading research institutions in France and Germany:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251210538867/en/AVANCE NEO 1 GHz system wi...
Themefolio
Profiler
Peergroup
© BusinessWire
08.12.2025
BRKR
LISTED
NASDAQ
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry.
This press release features multimedia. View...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2025
BRKR
LISTED
NASDAQ
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend
News Preview
Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock, par value $0.01 per share (the “Common Stock Dividend”). The Common Stock Dividend will be paid on January 2, 2026 to stockholders of record...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
03.11.2025
BRKR
LISTED
NASDAQ
Bruker Reports Third Quarter 2025 Financial Results
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and nine months ended September 30, 2025.
Frank H. Laukien, Bruker’s President and CEO, commented: “In the third quarter, we were encouraged by our mid-single digit percentage organic bookings growth year-over-year, with a Scientific Instruments segment book-to-bil...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
22.10.2025
BRKR
LISTED
NASDAQ
Bruker Announces Date and Time of Third Quarter 2025 Earnings Release and Webcast
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker....
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
BRKR
LISTED
NASDAQ
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performanc...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
BRKR
LISTED
NASDAQ
Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock
News Preview
Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 million of 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker has granted the underwriters a 30-day option to purchase up to an additiona...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
BRKR
LISTED
NASDAQ
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock
News Preview
Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced it has commenced a public offering, subject to market and other conditions, of $600.0 million of Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock”). Bruker expects to grant the underwriters a 30-day option to purchase...
Themefolio
Profiler
Peergroup
© BusinessWire
21.07.2025
BRKR
LISTED
NASDAQ
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constan...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
BRKR
LISTED
NASDAQ
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the shipment and installation of the 15th InSight WLI 3D optical metrology system to a leading semiconductor manufacturer. The installation is part of a larger order from this semiconductor manufacturer for 27 Bruker optical metrology systems in 2025. This reflects the growing demand for high-perfo...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
BRKR
LISTED
NASDAQ
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
News Preview
Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker’s continued investment in applied marke...
Themefolio
Profiler
Peergroup
© BusinessWire
03.06.2025
BRKR
LISTED
NASDAQ
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
News Preview
Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603323690/en/biocrates kits and pipettes
biocrates is a global leader in...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
02.06.2025
BRKR
LISTED
NASDAQ
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
News Preview
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significant further advances in ultra-high sensitivity 4D-Proteomics™ with the introduction of the timsUltra AIP mass spectrometer. Its innovative, breakthrough Athena Ion Processor (AIP) technology further boosts the extreme sen...
Themefolio
Profiler
Peergroup
© BusinessWire
02.06.2025
BRKR
LISTED
NASDAQ
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
News Preview
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteom...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time.
A live audio webcast of the presentation will be available on the Investor Relations sectio...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
BRKR
LISTED
NASDAQ
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer
News Preview
For the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) announced the launch of the timsOmni™ system, a transformative new timsTOF-based mass spectrometer designed for scientific, drug discovery, and clinical researchers, as well as for advanced QC on biologics, offering deep structural insights int...
Themefolio
Profiler
Peergroup
© BusinessWire
30.05.2025
BRKR
LISTED
NASDAQ
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale
News Preview
At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) launched timsMetabo, a peak-performance 4D-Metabolomics™ mass spectrometer delivering unprecedented sensitivity, separation power and annotation confidence for small molecules, further enhanced by the novel TIMS ‘MoRE’ scan-mode. The timsMetabo...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
BRKR
LISTED
NASDAQ
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the MOVE-T, a state-of-the-art liquid dairy analyzer designed to elevate quality control standards in the dairy industry. Utilizing advanced Fourier Transform Near-Infrared (FT-NIR) technology, the MOVE-T provides unparalleled precision analyzing raw milk and other liquid dairy produc...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
BRKR
LISTED
NASDAQ
Bruker Announces Quarterly Dividend
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on June 27, 2025 to stockholders of record as of June 16, 2025.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq:...
Themefolio
Profiler
Peergroup
© BusinessWire
14.05.2025
BRKR
LISTED
NASDAQ
Bruker and 10x Genomics Reach Global Settlement of Patent Litigation
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both...
Themefolio
Profiler
Peergroup
© BusinessWire
07.05.2025
BRKR
LISTED
NASDAQ
Bruker Reports First Quarter 2025 Financial Results
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2025.
Frank H. Laukien, Bruker’s President and CEO, commented: “Bruker had a solid start to 2025 with double-digit reported and CER revenue growth, 5.1% organic revenue growth in our BSI segment, and better operating margin performance than e...
Themefolio
Profiler
Peergroup
© BusinessWire
25.04.2025
BRKR
LISTED
NASDAQ
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, including launch of CosMx WTX assay for subcellular spatial imagi...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
BRKR
LISTED
NASDAQ
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis.
This press release features multimedia. View the fu...
Themefolio
Profiler
Peergroup
© BusinessWire
17.04.2025
BRKR
LISTED
NASDAQ
Bruker Introduces nVista 2P Miniature Microscope
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to the Inscopix product line for functional imaging of freely behaving animals. It leverages advanced two-photon fluorescence microscopy technology to enable high-resolution imaging at greater depths with 3D dat...
Themefolio
Profiler
Peergroup
© BusinessWire
16.04.2025
BRKR
LISTED
NASDAQ
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring
News Preview
Bruker Corporation (NASDAQ: BRKR) today announced a majority investment in RECIPE Chemicals + Instruments GmbH, based in Munich, Germany. RECIPE is a leading European provider of vendor-agnostic therapeutic drug monitoring (TDM) and other clinical in vitro diagnostic kits for LC-MS/MS, HPLC, and ICP-MS assays.
This press release features multimedi...
Themefolio
Profiler
Peergroup
© BusinessWire
11.04.2025
BRKR
LISTED
NASDAQ
Bruker Announces First Quarter 2025 Preliminary Revenue
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company’s earlier outlook and well ahead of consensus.
This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double di...
Themefolio
Profiler
Peergroup
© BusinessWire
11.04.2025
BRKR
LISTED
NASDAQ
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing
News Preview
At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of its microbiology solutions into Next-Generation Sequencing (NGS) applications, with new, research-use only NGS-based solutions in epidemiology and hospital acquired infection (HAI) tracing.
This press release features multi...
Themefolio
Profiler
Peergroup
© BusinessWire
07.04.2025
BRKR
LISTED
NASDAQ
Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System
News Preview
At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the successful development and testing of the world’s first high-resolution 1.3 GHz NMR spectrometer with a stable, standard-bore 54 mm superconducting magnet. This first-of-a-kind ultra-high field...
Themefolio
Profiler
Peergroup
© BusinessWire
07.04.2025
BRKR
LISTED
NASDAQ
Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR
News Preview
At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration. This novel Fourier 80 ‘Multi-Talent’ system represents a major advancemen...
Themefolio
Profiler
Peergroup
© BusinessWire
02.04.2025
BRKR
LISTED
NASDAQ
Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR
News Preview
Bruker Corporation today announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer at the 2025 Hyperpolarized Carbon-13 MRI Technology Development Workshop at the University of California San Francisco (UCSF) Hyperpolarized MRI Technology Resource Center. The first customer installation of this inn...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
BRKR
LISTED
NASDAQ
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
News Preview
Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demand...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
BRKR
LISTED
NASDAQ
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
News Preview
At the 21st Annual US HUPO Conference, Bruker Corporation (Nasdaq: BRKR) announces significant advances in 4D-Proteomics™ performance, software and applications for deeper biological insights.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250224096888/en/SCP-relevant 250 picogram samp...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
BRKR
LISTED
NASDAQ
Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. Bruker Spatial Biology will announce the following four innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering,...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
BRKR
LISTED
NASDAQ
Bruker Appoints Laura Francis to its Board of Directors
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker’s Audit Committee as a financial expert after Bruker’s annual shareholder meeting at the end of May 2025.
Laura F...
Themefolio
Profiler
Peergroup
© BusinessWire
21.02.2025
BRKR
LISTED
NASDAQ
Bruker Announces Quarterly Dividend
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasda...
Themefolio
Profiler
Peergroup
© BusinessWire
20.02.2025
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at Upcoming Investor Conferences
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences:
Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City
Thursday, February 27, 2025, at 2:30 p.m. Eastern Time
TD Cowen 45th Annual Health Care Conference in Boston, MA
Wednesday, March 5, 2025, at 11:10 a.m....
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
BRKR
LISTED
NASDAQ
Bruker Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024.
Frank H. Laukien, Bruker’s President and CEO, commented: “The year 2024 was transformational for Bruker. We completed several strategic acquisitions to access very large addressable markets with strong secular...
Themefolio
Profiler
Peergroup
© BusinessWire
07.02.2025
BRKR
LISTED
NASDAQ
Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends.
To listen to the webcast, investors...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2025
BRKR
LISTED
NASDAQ
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the launch of the LUMOS™ II ILIM, a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution.
This press rele...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2025
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
24.12.2024
BRKR
LISTED
NASDAQ
Bruker Comments on Delaware District Court’s Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products
News Preview
Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringem...
Themefolio
Profiler
Peergroup
© PR Newswire
23.12.2024
BRKR
LISTED
NASDAQ
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products
News Preview
PLEASANTON, Calif., Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from Na...
Themefolio
Profiler
Peergroup
© BusinessWire
20.12.2024
BRKR
LISTED
NASDAQ
Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
News Preview
Bruker announces the acceptance of a 1.2 GHz Ascend™ Nuclear Magnetic Resonance (NMR) spectrometer at the Swiss High-field NMR Facility, operated jointly by the University of Basel, ETH Zürich, and the University of Zürich. This state-of-the-art instrument will significantly enhance the research capabilities of several user groups, enabling advanc...
Themefolio
Profiler
Peergroup
© BusinessWire
02.12.2024
BRKR
LISTED
NASDAQ
Bruker Introduces Dimension Nexus™ Atomic Force Microscope
News Preview
At the 2024 MRS Fall Meeting & Exhibit, Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Dimension Nexus™ atomic force microscope (AFM). Dimension Nexus is the newest addition to the industry-leading Dimension® AFM product line, which has had more than 4600 systems installed around the world. With the latest-generation NanoS...
Themefolio
Profiler
Peergroup
© BusinessWire
18.11.2024
BRKR
LISTED
NASDAQ
Bruker Announces Quarterly Dividend
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on December 16, 2024 to stockholders of record as of December 2, 2024.
About Bruker Corporation – Leader of the Post-Genomic Era...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at Upcoming Investor Conferences
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:
Stifel 2024 Healthcare Conference in New York City
Monday, November 18, 2024, at 8:35 a.m. Eastern Time
Wolfe Research 2024 Healthcare Conference in New York City...
Themefolio
Profiler
Peergroup
© BusinessWire
08.11.2024
BRKR
LISTED
NASDAQ
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced a major technological breakthrough in the CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the CellScape platform has advanced the field of spatial proteomics with differentiated quantitative performance enabled by a unique combination...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2024
BRKR
LISTED
NASDAQ
Bruker Reports Third Quarter 2024 Financial Results
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2024.
Frank H. Laukien, Bruker’s President and CEO, commented: “Bruker has again posted double-digit year-over-year CER revenue growth, and above-market organic revenue growth, in Q3 and year-to-date. This is a tes...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2024
BRKR
LISTED
NASDAQ
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2024 financial results before market opening on Tuesday, November 5, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends.
To listen to the webcast, investors can go to https://ir.bruker....
Themefolio
Profiler
Peergroup
© BusinessWire
21.10.2024
BRKR
LISTED
NASDAQ
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
News Preview
At the 23rd Human Proteome Organization World Congress, Bruker Corporation (Nasdaq: BRKR) announces advances in deep, unbiased and high-sensitivity 4D-Proteomics for robust, high- fidelity, large-scale studies - avoiding inherent cross-talk of affinity high-plex technologies.
This press release features multimedia. View the full release here: http...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2024
BRKR
LISTED
NASDAQ
European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the “928 Patent”), which has been asserted by 10x Genomics against NanoString’s CosMx® Spatial Molecular Imager (SMI) products in Europe. Today’s ruling follows th...
Themefolio
Profiler
Peergroup
© BusinessWire
11.10.2024
BRKR
LISTED
NASDAQ
Bruker Announces Formation of New Bruker Spatial Biology Division
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the formation of a new division, Bruker Spatial Biology, offering the most diverse and comprehensive solutions for spatial biology. Bruker Spatial Biology brings together in operational coordination three entities: the two businesses of NanoString Technologies and Canopy Biosciences, along with its...
Themefolio
Profiler
Peergroup
© BusinessWire
07.10.2024
BRKR
LISTED
NASDAQ
Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
News Preview
At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) today announced the release of the OptoVolt™ module to further expand the advanced neuroscience research capabilities on Bruker’s Ultima multiphoton microscope platform. OptoVolt accelerates imaging speeds to beyond 1000 frames per second for the capture of millisecond dynamics...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2024
BRKR
LISTED
NASDAQ
Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker’s biophysical portfolio for the analysis of molecular interactions and kinetics, offering deeper insights int...
Themefolio
Profiler
Peergroup
© BusinessWire
23.08.2024
BRKR
LISTED
NASDAQ
Bruker Corporation to Present at Upcoming Investor Conferences
News Preview
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:
2024 Wells Fargo Healthcare Conference in Boston, MA
Wednesday, September 4, 2024, at 10:15 a.m. Eastern Time
Morgan Stanley 22nd Annual Global Healthcare Conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2024
BRKR
LISTED
NASDAQ
Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI)
News Preview
Bruker Corporation is pleased to announce the successful installation and acceptance of a 1.2 GHz Avance® Nuclear Magnetic Resonance (NMR) spectrometer at the Korea Basic Science Institute (KBSI), just in time before the start of the ICMRBS 2024 conference in Korea. As the first 1.2 GHz NMR system in the Asia-Pacific region, it sets a new benchmar...
Themefolio
Profiler
Peergroup
© BusinessWire
12.08.2024
BRKR
LISTED
NASDAQ
Bruker Announces Quarterly Dividend
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on September 16, 2024 to stockholders of record as of September 2, 2024.
About Bruker Corporation – Leader of the Post-Genomic Er...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
